Introduction Newborn Screening (NBS) is vital for the early diagnosis of inherited metabolic disorders (IMDs) that cause unnecessary emotional burden and socioeconomic challenges for the affected families. According to Child Mortality Report of 2017, congenital disorders contributed 11% to the deaths in children aged <5 years and Pakistan is one of the five countries that accounted for half of all newborn deaths. 1 If IMDs are diagnosed in infancy and treated as prescribed, the disease management can prove life- saving. 2 Congenital hypothyroidism (CH) is one of the most abundant of the IMDs found in Pakistan. It is considered to be the common cause of mental retardation. 3 The worldwide incidence of CH is 1 in 4000. 4 In a recent study conducted in a tertiary care hospital of Lahore, despite its very small sample size (770), high frequency of congenital hypothyroidism was reported to be 1 in 257 patients. 3 In another study done in Islamabad, the incidence was 3 in 1337 babies. 5 The decrease in thyroid stimulating hormone (TSH) threshold over time with technological advancement has increased the sensitivity and specificity of NBS equipment. 6,7 This has ultimately resulted in an increased reported incidence of CH. 8 Generally, TSH cut-off <15 U/L Vol. 71, No. 1-B, January 2021 191 ORIGINAL ARTICLE Diagnostic evaluation of heel prick newborn screening of thyroid stimulating hormone on dissociation-enhanced lanthanide fluorescence immunoassay with the establishment of reference value in Pakistani neonates Ayesha Raza, 1 Ambreen Barkat, 2 Safia Fatima, 3 Fizza Faizan Farooqui, 4 Naureen Chaudhri, 5 Shahzad Haider 6 Abstract Objective: To develop and validate a method on Dissociation Enhanced Lanthanide Fluorescence Immunoassay for neonatal heel prick blood human thyroid stimulating hormone and the establishment of its reference value in the local population. Methods: The multi-centre cross-sectional validation study was conducted from September 2016 to September 2018 at Zahra Beau Naqvi Foundation Welfare Trust laboratory, Islamabad, Pakistan, and comprised samples related to newborns aged 1 month or less taken from neonatal units of 39 hospitals based in Punjab, Khyber Pakhtunkhuwa, Gilgit-Baltistan and Azad Jammu and Kashmir. Samples were collected after 24 hours of birth using the heel prick test. The samples were dried and sent to the laboratory for assessment where Dissociation Enhanced Lanthanide Fluorescent Immunoassay was used to estimate thyroid stimulating hormone levels. Data recorded included age, gender, and birth detail, like gestational age, mode of delivery etc. Data was analysed using SPSS 21. Method validation and reference value were manually calculated. Results: Of the 14,147 samples received, 8,207(58%) related to boys and 5,940(42%) to girls. Most samples 4903(34.6%) came from Peshawar. The overall mean age of the newborns was 5.6±4.8 days. Thyroid stimulating hormone data was divided into three groups; positive with median value 27.8±36.6 uIU/ml, negative with median 1.42±1.60 uIU/ml, and borderline with median 11.4±4.12uIU/ml. Prevalence of congenital hypothyroidism in high- risk population in the positive group was 39(0.3%), negative 14,012(99.0%) and borderline 96(0.7%). Reference cut- off was calculated as 7.06uIU/ml for screening of healthy and positive cases of congenital hypothyroidism. Method Validation results showed limit of detection -0.5uU/ml, limit of quantitation LOQ 0.8uU/ml, accuracy 100±5%, precision coefficient of variation at each level of calibrators -4, 8.8, 1.2, 11.3, 7.2 and 4.3% respectively, and linearity from to 0.8uU/ml to 254.1uU/ml. Conclusion: Neonatal human thyroid stimulating hormone by heel prick blood was found to be an affordable and highly sensitive method of screening for congenital hypothyroidism. Keywords: DELFIA, Dissociation enhanced fluorescence immunoassay, Newborn screening, Congenital hypothyroidism. (JPMA 71: 191; 2021) DOI: https://doi.org/10.47391/JPMA.561 1,2,4 Newborn Screening Lab, The ZB foundation Welfare Trust, Rawalpindi, 3 Department of Chemical Pathology and Endocrinology, Armed Forces Institute of Pathology and National University of Medical Sciences, Rawalpindi, 5 Rawalpindi Medical University RMU, Rawalpindi, 6 Izzat Ali Shah Hospital, Wah, Rawalpindi, Pakistan. Correspondence: Ayesha Raza. Email: ayesha@thezbfoundation.com